U.S. flag An official website of the United States government
  1. Home
  2. For Industry
  3. FDA User Fee Programs
  4. Prescription Drug User Fee Amendments
  5. General CMA Pilot 2 program criteria text box
  1. Prescription Drug User Fee Amendments

General CMA Pilot 2 program criteria text box

General CMA Pilot 2 program criteria: • Product must be Fast-Track • Must have had an End-of-Phase 1, or equivalent meeting • Must not be on clinical hold • Only one Pilot 2 product per CDER/CBER review division Other FDA considerations for applicants: • Potential value of enhanced interaction (public health benefit resulting from development of the product) • Likelihood that concentrated scientific dialogue will facilitate the availability of a promising novel therapy • Demonstration of commitment to product development